Rod photoreceptor differentiation in fetal and infant human retina.
Human rods and cones are arranged in a precise spatial mosaic that is critical for optimal functioning of the visual system. However, the molecular processes that underpin specification of cell types within the mosaic are poorly understood. The progressive differentiation of human rods was tracked from fetal week (Fwk) 9 to postnatal (P) 8 months using immunocytochemical markers of key molecules that represent rod progression from post-mitotic precursors to outer segment-bearing functional photoreceptors. We find two phases associated with rod differentiation. The early phase begins in rods on the foveal edge at Fwk 10.5 when rods are first identified, and the rod-specific proteins NRL and NR2e3 are detected. By Fwk 11-12, these rods label for interphotoreceptor retinoid binding protein, recoverin, and aryl hydrocarbon receptor interacting protein-like 1. The second phase occurs over the next month with the appearance of rod opsin at Fwk 15, closely followed by the outer segment proteins rod GTP-gated sodium channel, rod arrestin, and peripherin. TULP is expressed relatively late at Fwk 18-20 in rods. Each phase proceeds across the retina in a central-peripheral order, such that rods in far peripheral retina are only entering the early phase at the same time that cells in central retina are entering their late phase. During the second half of gestation rods undergo an intracellular reorganization of these proteins, and cellular and OS elongation which continues into infancy. The progression of rod development shown here provides insight into the possible mechanisms underlying human retinal visual dysfunction when there are mutations affecting key rod-related molecules.
Hendrickson
Anita
A
Department of Biological Structure and Ophthalmology, University of Washington, Seattle, WA 98195, USA.
Bumsted-O'Brien
Keely
K
Natoli
Riccardo
R
Ramamurthy
Visvanathan
V
Possin
Daniel
D
Provis
Jan
J
D015415:Biomarkers / Q000378:metabolism; D002454:Cell Differentiation; D005136:Eye Proteins / Q000378:metabolism; D047109:Fetal Development / Q000235:genetics; D018507:Gene Expression Regulation, Developmental; D006801:Humans; D017403:In Situ Hybridization; D012333:RNA, Messenger / Q000235:genetics; D012160:Retina / Q000166:cytology / Q000196:embryology / Q000254:growth & development; D017948:Retinal Rod Photoreceptor Cells / Q000166:cytology* / Q000378:metabolism; D017299:Rod Opsins / Q000096:biosynthesis / Q000235:genetics; D014785:Vision, Ocular / Q000235:genetics
D015415:Biomarkers; D005136:Eye Proteins; D012333:RNA, Messenger; D017299:Rod Opsins
Mol Vis. 2004 Jan 08;10:1-14
14737068
Vis Neurosci. 1990 Jul;5(1):43-60
2271459
Eye (Lond). 1992;6 ( Pt 2):136-44
1624035
Stem Cells. 2007 Aug;25(8):2033-43
17525239
Int Rev Cytol. 2006;253:131-75
17098056
Vision Res. 1996 Nov;36(22):3711-22
8977001
Dev Biol. 1987 Jul;122(1):120-38
3596007
Acta Anat (Basel). 1998;162(2-3):85-94
9831754
J Comp Neurol. 1997 Feb 3;378(1):117-34
9120051
J Comp Neurol. 1991 Jul 1;309(1):86-114
1894769
Vis Neurosci. 2005 Jul-Aug;22(4):447-59
16212702
J Biol Chem. 2001 Sep 28;276(39):36824-30
11477108
Nat Genet. 1998 Feb;18(2):177-9
9462751
Nat Genet. 1999 Apr;21(4):355-6
10192380
Nat Genet. 2001 Dec;29(4):447-52
11694879
J Comp Neurol. 1985 Mar 22;233(4):429-51
3980779
Vis Neurosci. 1995 May-Jun;12(3):509-12
7654607
J Comp Neurol. 2000 Oct 2;425(4):545-59
10975879
Vis Neurosci. 1999 Mar-Apr;16(2):291-302
10367964
Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2352-6
10892883
J Comp Neurol. 1991 Oct 22;312(4):610-24
1722224
Nat Genet. 2001 Jan;27(1):94-8
11138006
Am J Anat. 1973 Aug;137(4):357-85
4730460
Mol Vis. 2003 Aug 28;9:401-9
12949469
Science. 1982 Jul 16;217(4556):265-7
6178160
Invest Ophthalmol Vis Sci. 1995 Dec;36(13):2634-51
7499086
J Comp Neurol. 1987 May 8;259(2):237-46
3584558
Prog Neurobiol. 1998 Apr;54(5):549-80
9550191
Mol Neurobiol. 2003 Oct;28(2):149-58
14576453
Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2807-12
15277507
Invest Ophthalmol Vis Sci. 1990 May;31(5):827-38
2335450
Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5396-403
14638743
Invest Ophthalmol Vis Sci. 1999 Jul;40(8):1878-83
10393065
J Comp Neurol. 1990 Feb 22;292(4):497-523
2324310
Invest Ophthalmol Vis Sci. 1999 Aug;40(9):2106-14
10440267
J Comp Neurol. 1994 Jan 22;339(4):535-58
8144745
J Comp Neurol. 1999 Jan 25;403(4):502-16
9888315
Vision Res. 1986;26(6):847-55
3750868
J Biosci. 2001 Jun;26(2):179-91
11426054
Behav Brain Res. 1992 Jul 31;49(1):21-31
1388798
Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):577-81
8570598
Vision Res. 1995 May;35(10):1473-81
7645276
Methods Enzymol. 2006;419:52-73
17141051
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):473-8
11773633
Ophthalmology. 1984 Jun;91(6):603-12
6462623
Brain Res. 1993 Jul 9;616(1-2):344-50
8358626
J Comp Neurol. 1999 Oct 18;413(2):198-208
10524333
J Comp Neurol. 1990 Jan 8;291(2):203-19
2298931
Invest Ophthalmol Vis Sci. 2001 Mar;42(3):804-15
11222544
Hum Mutat. 2001 Jun;17(6):520
11385710
Brain Behav Evol. 1988;31(6):369-90
3046710
Nat Genet. 2000 Feb;24(2):127-31
10655056